1. Home >
  2. M&A >
  3. Merger >
  4. France >
  5. Biosynex Acquires TheraDiag

M&A Deal Summary

Biosynex Acquires TheraDiag

On September 29, 2023, Biosynex acquired manufacturer TheraDiag

Acquisition Highlights
  • This is Biosynex’s 1st transaction in the Manufacturing sector.
  • This is Biosynex’s 3rd transaction in France.

M&A Deal Summary
Date 2023-09-29
Target TheraDiag
Sector Manufacturing
Buyer(s) Biosynex
Deal Type Merger

Target

TheraDiag

Croissy-Beaubourg, France
TheraDiag develops, produces, and markets in vitro diagnostics products in France and internationally. It offers auto-immunity products, such as FIDIS kits that allow detection of multiple analytes from the same sample in a single assay. TheraDiag was founded in 1986 and is based in Croissy-Beaubourg, France.

Search 215,058 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Biosynex

Illkirch-Graffenstaden, France
Category Company
Founded 2005
Sector Life Science
Employees176
Revenue 27M EUR (2016)
DESCRIPTION

Biosynex is a designer and distribution of rapid diagnostic tests. Biosynex develops, manufactures and markets Medical Devices for Screening, Diagnostics, and Prevention in a permanent quest for excellence. Biosynex was founded in 2008 and is based in Illkirch-Graffenstaden, France.

DEAL STATS #
Overall 5 of 5
Sector: Manufacturing M&A 1 of 1
Type: Merger M&A Deals 2 of 2
Country: France M&A 3 of 3
Year: 2023 M&A 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-06-13 ProciseDx

San Diego, California, United States

ProciseDx is a vitro diagnostics (IVD) company with a proprietary instrument platform and portfolio of Point of Care diagnostic tests, based in San Diego, California.

Buy -
Mergr

Solution for

Product

Company

Legal